Conmed (CNMD) Short term Debt (2010 - 2026)

Conmed (CNMD) has reported Short term Debt for 17 consecutive years, with $177.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short term Debt rose 24717.79% year-over-year to $177.2 million; the trailing twelve-month figure through Jun 2026 stood at $177.2 million (up 24717.79% YoY), and the FY2025 full-year result was $712000.0, changed 0.42% from the prior year.
• Short term Debt advanced to $177.2 million in Q2 2026 per CNMD's latest filing, from $711000.0 in the prior quarter.
• Across five years, Short term Debt topped out at $177.2 million in Q2 2026 and bottomed at $237000.0 in Q3 2022.
• Historically, Short term Debt has averaged $26.5 million across 5 years, with a median of $715500.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Short term Debt jumped 29699.58% in 2023, then sank 99.01% in 2024.
• Over 5 years, Short term Debt stood at $69.7 million in 2022, then sank by 98.98% to $708000.0 in 2023, then increased by 0.99% to $715000.0 in 2024, then declined by 0.42% to $712000.0 in 2025, then jumped by 24787.5% to $177.2 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $177.2 million, $711000.0, and $712000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.